The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2
Abstract
The mononuclear phagocytes control the body homeostasis through the involvement in resolving tissue injury and further wound healing. Indeed, local tissue microenvironmental changes can significantly influence the functional behavior of monocytes and macrophages. Such microenvironmental changes for example occur in an atherosclerotic plaque during all progression stages. In response to exogenous stimuli, macrophages show a great phenotypic plasticity and heterogeneity. Exposure of monocytes to inflammatory or anti-inflammatory conditions also induces predominant differentiation to proinflammatory (M1) or anti-inflammatory (M2) macrophage subsets and phenotype switch between macrophage subsets. The phenotype transition is accompanied with great changes in the macrophage transcriptome and regulatory networks. Interferon-regulatory factors (IRFs) play a key role in hematopoietic development of monocytes, their differentiation to macrophages, and regulating macrophage maturation, phenotypic polarization, phenotypic switch, and function. Of 9 IRFs, at least 3 (IRF-1, IRF-5, and IRF-8) are involved in the commitment of proinflammatory M1 whereas IRF-3 and IRF-4 control M2 polarization. The role of IRF-2 is context-dependent. The IRF impact on macrophage phenotype plasticity and heterogeneity is complex and involves activating and repressive function in triggering transcription of target genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IRF-5 is critically involved in M1- macrophage polarization (42)”
From mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model (2022) · cites this paper as [42]
In the citing paper
“which possesses phagocytic capacity, and the ability to secrete reactive nitrogen and oxygen species and pro-inflammatory cytokines such as IL-6, IL-12, IL-23 and TNF-α, which in turn promote CD8+ T cell and NK cell cytotoxicity.”
From mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model (2022) · cites this paper as [42]
Citations
Cites
1 retracted
Chistiakov, D. A., Bobryshev, Y. V., Nikiforov, N. G., Elizova, N. V., Sobenin, I. A., & Orekhov, A. N. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.055 · Cited by 184
RetractedMacrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,504
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003) · Science · doi:10.1126/science.1087262 · Cited by 3,286
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Ishikawa, H., Ma, Z., & Barber, G. N. (2009) · Nature · doi:10.1038/nature08476 · Cited by 2,759
Martínez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,399
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284
Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
Wang, N., Liang, H., & Zen, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00614 · Cited by 2,086
Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells
Auffray, C., Sieweke, M. H., & Geissmann, F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132557 · Cited by 1,745
Tacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28549 · Cited by 1,323
Świrski, F. K., Libby, P., Aïkawa, E., Alcaide, P., Luscinskas, F. W., Weissleder, R., & Pittet, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29950 · Cited by 1,308
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305
Satoh, T., Takeuchi, O., Vandenbon, A., Yasuda, K., Tanaka, Y., Kumagai, Y., Miyake, T., Matsushita, K., Okazaki, T., Saitoh, T., et al. (2010) · Nature Immunology · doi:10.1038/ni.1920 · Cited by 1,156
Macrophage Phenotype and Function in Different Stages of Atherosclerosis
Tabas, I., & Bornfeldt, K. E. (2016) · Circulation Research · doi:10.1161/circresaha.115.306256 · Cited by 1,121
Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors
Takaoka, A., Yanai, H., Kondo, S., Duncan, G. S., Negishi, H., Mizutani, T., Kano, S., Honda, K., Ohba, Y., Mak, T. W., et al. (2005) · Nature · doi:10.1038/nature03308 · Cited by 1,066
Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T., & Taniguchi, T. (1988) · Cell · doi:10.1016/s0092-8674(88)91307-4 · Cited by 971
De Santa, F., Totaro, M. G., Prosperini, E., Notarbartolo, S., Testa, G., & Natoli, G. (2007) · Cell · doi:10.1016/j.cell.2007.08.019 · Cited by 965
Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90107-4 · Cited by 957
The role of macrophage phenotype in vascularization of tissue engineering scaffolds
Spiller, K. L., Anfang, R. R., Spiller, K. J., Ng, J., Nakazawa, K. R., Daulton, J. W., & Vunjak-Novakovic, G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.012 · Cited by 948
Distinct macrophage phenotypes contribute to kidney injury and repair
Lee, S., Huen, S., Nishio, H., Nishio, S., Lee, H. K., Choi, B.-S., Ruhrberg, C., & Cantley, L. G. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060615 · Cited by 906
Monocytes in atherosclerosis: subsets and functions
Woollard, K. J., & Geissmann, F. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.228 · Cited by 890
Biswas, S. K. (2005) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 691
Zizzo, G., Hilliard, B. A., Monestier, M., & Cohen, P. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200662 · Cited by 675
Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644
Regulation of Macrophage Polarization and Wound Healing
Ferrante, C., & Leibovich, S. J. (2012) · Advances in Wound Care · doi:10.1089/wound.2011.0307 · Cited by 619
Fleetwood, A. J., Lawrence, T., Hamilton, J. A., & Cook, A. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5245 · Cited by 607
Adhesion mechanisms regulating the migration of monocytes
Imhof, B. A., & Aurrand‐Lions, M. (2004) · Nature reviews. Immunology · doi:10.1038/nri1375 · Cited by 604
Interferon Regulatory Factor 6 ( IRF6 ) Gene Variants and the Risk of Isolated Cleft Lip or Palate
Zucchero, T. M., Cooper, M. E., Maher, B. S., Daack‐Hirsch, S., Nepomuceno, B., Ribeiro, L. A., Caprau, D., Christensen, K., Suzuki, Y. A., Machida, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032909 · Cited by 579
The enhanceosome and transcriptional synergy.
Carey, M. (1998) · Cell · doi:10.1016/s0092-8674(00)80893-4 · Cited by 553
Jaguin, M., Houlbert, N., Fardel, O., & Lecureur, V. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.01.010 · Cited by 547
Defining GM-CSF– and Macrophage-CSF–Dependent Macrophage Responses by In Vitro Models
Lacey, D. C., Achuthan, A. A., Fleetwood, A. J., Dinh, H., Roiniotis, J., Scholz, G. M., Chang, M. W., Beckman, S. K., Cook, A. D., & Hamilton, J. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103426 · Cited by 528
Macrophage plasticity in experimental atherosclerosis
Khallou-Laschet, J., Varthaman, A., Fornasa, G., Compain, C., Gaston, A.-T., Clement, M., Dussiot, M., Levillain, O., Graff-Dubois, S., Nicoletti, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008852 · Cited by 517
Macrophage‐mediated cholesterol handling in atherosclerosis
Chistiakov, D. A., Bobryshev, Y. V., & Orekhov, A. N. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12689 · Cited by 513
Epigenetic regulation of the alternatively activated macrophage phenotype
Ishii, M., Wen, H., Corsa, C. A. S., Liu, T., Coelho, A. L., Allen, R., Carson, W. F., Cavassani, K. A., Li, X., Lukacs, N. W., et al. (2009) · Blood · doi:10.1182/blood-2009-04-217620 · Cited by 505
The growing family of interferon regulatory factors
Nguyen, H., Hiscott, J., & Pitha, P. M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00019-1 · Cited by 480
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447
Xu, H., Zhu, J., Smith, S. M., Foldi, J., Zhao, B., Chung, A. Y., Outtz, H. H., Kitajewski, J., Shi, C., Weber, S., et al. (2012) · Nature Immunology · doi:10.1038/ni.2304 · Cited by 442
The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling
Schoenemeyer, A., Barnes, B. J., Mancl, M. E., Latz, E., Goutagny, N., Pitha, P. M., Fitzgerald, K. A., & Golenbock, D. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412584200 · Cited by 411
Structure of IRF-1 with bound DNA reveals determinants of interferon regulation
Escalante, C. R., Yie, J., Thanos, D., & Aggarwal, A. K. (1998) · Nature · doi:10.1038/34224 · Cited by 397
Geissmann, F., Auffray, C., Palframan, R. T., Wirrig, C., Ciocca, A., Campisi, L., Narni-Mancinelli, É., & Lauvau, G. S. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.19 · Cited by 396
The Mechanism of Transcriptional Synergy of an In Vitro Assembled Interferon-β Enhanceosome
Kim, T. K., & Maniatis, T. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80013-1 · Cited by 340
Davies, P. F., Civelek, M., Fang, Y. H., & Fleming, I. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt101 · Cited by 338
IRF8 Is a Critical Transcription Factor for Transforming Microglia into a Reactive Phenotype
Masuda, T., Tsuda, M., Yoshinaga, R., Tozaki-Saitoh, H., Ozato, K., Tamura, T., & Inoue, K. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.02.014 · Cited by 338
Lin, R., Heylbroeck, C., Génin, P., Pitha, P., & Hiscott, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.959 · Cited by 325
Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch
Richardson, R. J., Dixon, J., Malhotra, S., Hardman, M. J., Knowles, L., Boot-Handford, R., Shore, P., Whitmarsh, A. J., & Dixon, M. J. (2006) · Nature Genetics · doi:10.1038/ng1894 · Cited by 325
Lin, R., Mamane, Y., & Hiscott, J. B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2465 · Cited by 321
Endoplasmic Reticulum Stress Controls M2 Macrophage Differentiation and Foam Cell Formation
Oh, J., Riek, A. E., Weng, S., Petty, M., Kim, D., Colonna, M., Cella, M., & Bernal‐Mizrachi, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338673 · Cited by 313
Negishi, H., Fujita, Y., Yanai, H., Sakaguchi, S., Ouyang, X., Shinohara, M., Takayanagi, H., Ohba, Y., Taniguchi, T., & Honda, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607181103 · Cited by 310
Regulation of immunity and oncogenesis by the IRF transcription factor family
Savitsky, D., Tamura, T., Yanai, H., & Taniguchi, T. (2010) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-009-0804-6 · Cited by 298
Malyshev, I. Y., & Malyshev, Y. (2015) · BioMed Research International · doi:10.1155/2015/341308 · Cited by 293
Courties, G., Heidt, T., Sebas, M., Iwamoto, Y., Jeon, D., Truelove, J. J., Tricot, B., Wojtkiewicz, G. R., Dutta, P., Sager, H. B., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.023 · Cited by 285
Macrophage Subpopulations Are Essential for Infarct Repair With and Without Stem Cell Therapy
Ben-Mordechai, T., Holbová, R., Landa‐Rouben, N., Harel-Adar, T., Feinberg, M. S., Elrahman, I. A., Blum, G., Epstein, F. H., Silman, Z., Cohen, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.057 · Cited by 268
Integrated Regulation of Toll-like Receptor Responses by Notch and Interferon-γ Pathways
Hu, X., Chung, A. Y., Wu, I., Foldi, J., Chen, J., Ji, J. D., Tateya, T., Kang, Y. J., Han, J., Gessler, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.016 · Cited by 261
The IRF family of transcription factors: Inception, impact and implications in oncogenesis
Yanai, H., Negishi, H., & Taniguchi, T. (2012) · OncoImmunology · doi:10.4161/onci.22475 · Cited by 261
Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation
Kurotaki, D., Osato, N., Nishiyama, A., Yamamoto, M., Ban, T., Sato, H., Nakabayashi, J., Umehara, M., Miyake, N., Matsumoto, N., et al. (2013) · Blood · doi:10.1182/blood-2012-06-437863 · Cited by 252
Brass, A. L., Kehrli, E., Eisenbeis, C. F., Storb, U., & Singh, H. (1996) · Genes & Development · doi:10.1101/gad.10.18.2335 · Cited by 242
Fujii, Y., Shimizu, T., Kusumoto, M., Kyogoku, Y., Taniguchi, T., & Hakoshima, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5028 · Cited by 223
Macrophage Phenotypes and Their Modulation in Atherosclerosis
Paoli, F. D., Staels, B., & Chinetti, G. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0621 · Cited by 214
Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation
Qin, B. Y., Liu, C., Lam, S. S., Srinath, H., Delston, R. B., Correia, J. J., Derynck, R., & Lin, K. F. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb1002 · Cited by 214
Sancéau, J., Kaisho, T., Hirano, T., & Wietzerbin, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27920 · Cited by 211
Minimally modified low density lipoprotein is biologically active in vivo in mice.
Liao, F., Berliner, J. A., Mehrabian, M., Navab, M., Demer, L. L., Lusis, A. J., & Fogelman, A. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115261 · Cited by 210
Sierra‐Filardi, E., Vega, M. A., Sánchez‐Mateos, P., Corbí, A. L., & Puig‐Kröger, A. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.05.020 · Cited by 209
Kong, H. J., Anderson, D. E., Lee, C. H., Jang, M. K., Tamura, T., Tailor, P. B., Cho, H. K., Cheong, J., Xiong, H., Morse, H. C., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.26 · Cited by 207
Brass, A. L., Zhu, A. Q., & Singh, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.977 · Cited by 204
Liu, J., Cao, S., Herman, L. M., & Ma, X. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030026 · Cited by 186
Interferon Regulatory Factor 3 Is Regulated by a Dual Phosphorylation-dependent Switch
Panne, D., McWhirter, S. M., Maniatis, T., & Harrison, S. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703019200 · Cited by 178
IFN-γ Represses IL-4 Expression via IRF-1 and IRF-2
Elser, B., Lohoff, M. D., Kock, S., Giaisi, M., Kirchhoff, S., Krammer, P. H., & Li‐Weber, M. (2002) · Immunity · doi:10.1016/s1074-7613(02)00471-5 · Cited by 175
Chen, S., Ma, J., Wu, F., Xiong, L.-J., Ma, H., Xu, W., Lyu, R., Li, X., Villén, J., Gygi, S. P., et al. (2012) · Genes & Development · doi:10.1101/gad.186056.111 · Cited by 173
Interferon-Regulatory Factors Determine Macrophage Phenotype Polarization
Günthner, R., & Anders, H. (2013) · Mediators of Inflammation · doi:10.1155/2013/731023 · Cited by 172
Tarassishin, L., Suh, H.-S., & Lee, S. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-187 · Cited by 169
Bovolenta, C., Driggers, P. H., Marks, M. S., Medin, J. A., Politis, A. D., Vogel, S. N., Levy, D. E., Sakaguchi, K., Appella, E., & Coligan, J. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5046 · Cited by 167
Macrophage-mediated injury and repair after ischemic kidney injury
Huen, S. C., & Cantley, L. G. (2014) · Pediatric Nephrology · doi:10.1007/s00467-013-2726-y · Cited by 166
Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53
Mori, T., Anazawa, Y., Iiizumi, M., Fukuda, S., Nakamura, Y., & Arakawa, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205459 · Cited by 164
Sharf, R., Meraro, D., Azriel, A., Thornton, A. M., Ozato, K., Petricoin, E. F., Larner, A. C., Schaper, F., Hauser, H., & Levi, B.-Z. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9785 · Cited by 162
Fehr, T., Schoedon, G., Odermatt, B., Holtschke, T., Schneemann, M., Bachmann, M. F., Mak, T. W., Horak, I., & Zinkernagel, R. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.921 · Cited by 162
Wolfs, I., Donners, M., & de Winther, M. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0320 · Cited by 157
Nehyba, J., Hrdličková, R., & Bose, H. R. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp167 · Cited by 153
Meraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6468 · Cited by 147
Becker, A. M., Michael, D. G., Satpathy, A. T., Sciammas, R., Singh, H., & Bhattacharya, D. (2012) · Blood · doi:10.1182/blood-2011-06-364976 · Cited by 144
Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3
Zhang, M., Tian, Y., Wang, R., Gao, D., Zhang, Y., Diao, F., Chen, D., Zhai, Z., & Shu, H. (2008) · Cell Research · doi:10.1038/cr.2008.277 · Cited by 144
Honma, K., Udono, H., Kohno, T., Yamamoto, K., Ogawa, A., Takemori, T., Kumatori, A., Suzuki, S., Matsuyama, T., & Yui, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504226102 · Cited by 143
Chronic exposure to TGFβ1 regulates myeloid cell inflammatory response in an IRF7-dependent manner
Cohen, M., Matcovitch, O., David, E., Barnett‐Itzhaki, Z., Keren‐Shaul, H., Blecher‐Gonen, R., Jaitin, D. A., Sica, A., Amit, I., & Schwartz, M. (2014) · The EMBO Journal · doi:10.15252/embj.201489293 · Cited by 142
Regulation of myelopoiesis by the transcription factor IRF8
Tamura, T., Kurotaki, D., & Koizumi, S.-I. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1761-9 · Cited by 139
Blanco, J. C. G., Contursi, C., Salkowski, C. A., DeWitt, D. L., Ozato, K., & Vogel, S. N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.12.2131 · Cited by 137
IFN Regulatory Factor 4 Regulates the Expression of a Subset of Th2 Cytokines
Ahyi, A.-N. N., Chang, H.-C., Dent, A. L., Nutt, S. L., & Kaplan, M. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803302 · Cited by 137
A dual cis -regulatory code links IRF8 to constitutive and inducible gene expression in macrophagesPreprint
Mancino, A., Termanini, A., Barozzi, I., Ghisletti, S., Ostuni, R., Prosperini, E., Ozato, K., & Natoli, G. (2015) · Genes & Development · doi:10.1101/gad.257592.114 · Cited by 131
Crystal Structure of IRF-3 in Complex with CBP
Qin, B. Y., Liu, C., Srinath, H., Lam, S. S., Correia, J. J., Derynck, R., & Lin, K. F. (2005) · Structure · doi:10.1016/j.str.2005.06.011 · Cited by 131
Hiasa, M., Abe, M., Nakano, A., Oda, A., Amou, H., Kido, S., Takeuchi, K., Kagawa, K., Yata, K., Hashimoto, T., et al. (2009) · Blood · doi:10.1182/blood-2009-04-215020 · Cited by 130
Foldi, J., Chung, A. Y., Xu, H., Zhu, J., Outtz, H. H., Kitajewski, J., Li, Y., Hu, X., & Ivashkiv, L. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001544 · Cited by 128
Balkhi, M. Y., Fitzgerald, K. A., & Pitha, P. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00662-08 · Cited by 128
Chartouni, C. E., Schwarzfischer, L., & Rehli, M. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.05.031 · Cited by 125
Interferon regulatory factor 7 participates in the M 1‐like microglial polarization switch
Tanaka, T., Murakami, K., Bandô, Y., & Yoshida, S. (2014) · Glia · doi:10.1002/glia.22770 · Cited by 123
IRF8 regulates myeloid and B lymphoid lineage diversification
Wang, H., & Morse, H. C. (2008) · Immunologic Research · doi:10.1007/s12026-008-8055-8 · Cited by 121
Grinberg, S., Haskó, G., Wu, D., & Leibovich, S. J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090290 · Cited by 113
Marecki, S., Riendeau, C. J., Liang, M. D., & Fenton, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6829 · Cited by 111
Iadecola, C., Salkowski, C. A., Zhang, F., Aber, T., Nagayama, M., Vogel, S. N., & Ross, M. E. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.719 · Cited by 111
Liu, J., Guan, X., Tamura, T., Ozato, K., & Ma, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406565200 · Cited by 110
PIAS3 induces SUMO‐1 modification and transcriptional repression of IRF‐1
Nakagawa, K., & Yokosawa, H. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03486-5 · Cited by 109
Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: Implication in atherosclerosis
Brochériou, I., Maouche, S., Durand, H., Braunersreuther, V., Naour, G. L., Gratchev, A. N., Koskas, F., Mach, F., Kzhyshkowska, J. G., & Ninio, E. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.11.023 · Cited by 104
IKKβ is an IRF5 kinase that instigates inflammation
Ren, J., Chen, X., & Chen, Z. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418516111 · Cited by 104
Changes in transcriptome of macrophages in atherosclerosis
Chistiakov, D. A., Bobryshev, Y. V., & Orekhov, A. N. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12591 · Cited by 103
López‐Peláez, M., Lamont, D. J., Peggie, M. W., Shpiro, N., Gray, N. S., & Cohen, P. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418399111 · Cited by 100
Sharf, R., Azriel, A., Lejbkowicz, F., Winograd, S. S., Ehrlich, R., & Levi, B.-Z. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13063 · Cited by 100
XIE, C., Liu, C., Wu, B., Yan, L., Ma, T., Xiong, H.-Y., Wang, Q., Li, Z., Ma, C., & Tu, Z. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2583 · Cited by 100
Functional domains of interferon regulatory factor I (IRF-1)
Schaper, F., KIRCHHOFF, S., Posern, G., Köster, M., Oumard, A., Sharf, R., Levi, B.-Z., & Häuser, H. (1998) · Biochemical Journal · doi:10.1042/bj3350147 · Cited by 94
Sun, L., Zhou, H., Zhu, Z., Qian, Y., Wang, L., Liang, Q., & Ye, R. D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402164 · Cited by 90
Monocyte Differentiation to Macrophage Requires Interferon Regulatory Factor 7
Lu, R., & Pitha, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100421200 · Cited by 89
Essential control of early B-cell development by Mef2 transcription factors
Herglotz, J., Unrau, L., Hauschildt, F., Fischer, M., Kriebitzsch, N., Alawi, M., Indenbirken, D., Spohn, M., Müller, U., Ziegler, M., et al. (2015) · Blood · doi:10.1182/blood-2015-04-643270 · Cited by 89
Marecki, S., Atchison, M. L., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2713 · Cited by 87
IRF‐8/ICSBP and IRF‐1 cooperatively stimulate mouse IL‐12 promoter activity in macrophages
Masumi, A., Tamaoki, S., Wang, I., Ozato, K., & Komuro, K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03556-1 · Cited by 87
Bibeau-Poirier, A., Gravel, S., Clément, J.-F., Rolland, S., Rodier, G., Coulombe, P., Hiscott, J. B., Grandvaux, N., Meloche, S., & Servant, M. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5059 · Cited by 87
Gupta, M., Shin, D.-M., Ramakrishna, L., Goussetis, D. J., Platanias, L. C., Xiong, H., Morse, H. C., & Ozato, K. (2015) · Nature Communications · doi:10.1038/ncomms7379 · Cited by 86
Filonzi, E. L., Zoellner, H. F., Stanton, H., & Hamilton, J. A. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90026-q · Cited by 84
A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity
Lin, R., Lin, R., Hiscott, J. B., Hiscott, J. B., & Hiscott, J. B. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006850009017 · Cited by 77
KAP1/TRIM28: an inhibitor of IRF5 function in inflammatory macrophages.
Eames, H. L., Saliba, D. G., Krausgruber, T., Lanfrancotti, A., Ryzhakov, G., & Udalova, I. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.026 · Cited by 77
Activation of Interferon Regulatory Factor 5 by Site Specific Phosphorylation
Foreman, H.-C. C., Scoy, S. V., Cheng, T., & Reich, N. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033098 · Cited by 76
Molecular control of monocyte development
Terry, R. L., & Miller, S. D. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.02.008 · Cited by 75
PU.1/Interferon Regulatory Factor Interactions; Mechanisms of Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:33:2:127 · Cited by 74
Neddylation and deneddylation in cardiac biology.
Kandala, S., Kim, I., & Su, H. (2014) · Europe PMC (PubMed Central) · Cited by 73
Identification of IFN Regulatory Factor-1 Binding Site in IL-12 p40 Gene Promoter
Maruyama, S., Sumita, K., Shen, H., Kanoh, M., Xu, X., Sato, M., Matsumoto, M., Shinomiya, H., & Asano, Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.997 · Cited by 72
Expression of the Immune Regulator Tripartite-Motif 21 Is Controlled by IFN Regulatory Factors
Sjöstrand, M., Ambrosi, A., Brauner, S., Sullivan, J. M., Malin, S., Kuchroo, V. K., Espinosa, A., & Wahren‐Herlenius, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202341 · Cited by 69
Regulation of Lipopolysaccharide Sensitivity by IFN Regulatory Factor-2
Cuesta, N., Salkowski, C. A., Thomas, K. E., & Vogel, S. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5739 · Cited by 68
IRF-1 Promotes Inflammation Early after Ischemic Acute Kidney Injury
Wang, Y., John, R., Chen, J., Richardson, J. A., Shelton, J. M., Bennett, M., Zhou, X. J., Nagami, G. T., Zhang, Y., Wu, Q., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080843 · Cited by 67
Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis
Rojas, J., Salazar, J. J., Martínez, M. S., Palmar, J., Bautista, J., Chávez-Castillo, M., Gómez, A., & Bermúdez, V. (2015) · Scientifica · doi:10.1155/2015/851252 · Cited by 65
Plenz, G. A. M., Koenig, C., Severs, N. J., & Robenek, H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2489 · Cited by 64
Nhu, Q. M., Cuesta, N., & Vogel, S. N. (2006) · Journal of Endotoxin Research · doi:10.1179/096805106x118834 · Cited by 59
Huang, W., Horvath, E., & Eklund, E. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607760200 · Cited by 58
O’Reilly, D., Quinn, C. M., El‐Shanawany, T., Gordon, S., & Greaves, D. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212150200 · Cited by 56
Zhu, M., Fang, T., Li, S., Meng, K., & Guo, D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500232 · Cited by 52
IRF8 is a transcriptional determinant for microglial motility
Masuda, T., Nishimoto, N., Tomiyama, D., Matsuda, T., Tozaki‐Saitoh, H., Tamura, T., Kohsaka, S., Tsuda, M., & Inoue, K. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9413-8 · Cited by 51
Chang, T.-H., Xu, S., Tailor, P. B., Kanno, T., & Ozato, K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201104 · Cited by 51
Laricchia‐Robbio, L., Tamura, T., Karpova, T., Sprague, B. L., McNally, J. G., & Ozato, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504014102 · Cited by 48
Activation and Function of Interferon Regulatory Factor 5
Ryzhakov, G., Eames, H. L., & Udalova, I. A. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0023 · Cited by 44
IKKα negatively regulates IRF-5 function in a MyD88–TRAF6 pathway
Balkhi, M. Y., Fitzgerald, K. A., & Pitha, P. M. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.09.021 · Cited by 42
Terry, R. L., Deffrasnes, C., Getts, D. R., Minten, C., van Vreden, C., Ashhurst, T. M., Getts, M. T., Xie, R. D. V., Campbell, I. L., & King, N. J. C. (2015) · Journal of Innate Immunity · doi:10.1159/000365972 · Cited by 40
Interferon regulatory factor 8 protects against cerebral ischaemic‐reperfusion injury
Xiang, M., Wang, L., Guo, S., Lu, Y., Lei, H. C., Jiang, D., Zhang, Y., Liu, Y., Zhou, Y., Zhang, X., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12682 · Cited by 39
Interferon regulatory factor-2 is protective against hepatic ischemia-reperfusion injury
Klune, J. R., Dhupar, R., Kimura, S., Ueki, S., Cardinal, J. S., Nakao, A., Nace, G., Evankovich, J. W., Murase, N., Tsung, A., et al. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00050.2012 · Cited by 38
Pettersson, S., Kelleher, M., Pion, E., Wallace, M., & Ball, K. L. (2008) · Biochemical Journal · doi:10.1042/bj20082087 · Cited by 37
Cuesta, N., Nhu, Q. M., Zudaire, E., Polumuri, S. K., Cuttitta, F. F., & Vogel, S. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3602 · Cited by 36
Phosphoinositide Protein Kinase PDPK1 Is a Crucial Cell Signaling Mediator in Multiple Myeloma
Chinen, Y., Kuroda, J., Shimura, Y., Nagoshi, H., Kiyota, M., Yamamoto‐Sugitani, M., Mizutani, S., Sakamoto, N., Ri, M., Kawata, E., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1420 · Cited by 36
IκB Kinase ε Targets Interferon Regulatory Factor 1 in Activated T Lymphocytes
Sgarbanti, M., Marsili, G., Remoli, A. L., Stellacci, E., Mai, A., Rotili, D., Perrotti, E., Acchioni, C., Orsatti, R., Iraci, N., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01161-13 · Cited by 35
Regulation of IRF2 transcriptional activity by its sumoylation
Han, K.-J., Jiang, L., & Shu, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.103 · Cited by 33
Sakai, M., Biwa, T., Matsumura, T., Takemura, T., Matsuda, H., Anami, Y., Sasahara, T., Kobori, S., & Shichiri, M. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1726 · Cited by 32
Alexander, M., Forster, C. L., Sugimoto, K., Clark, H. B., Vogel, S. N., Ross, M. E., & Iadecola, C. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0658-x · Cited by 31
Interplay between repressing and activating domains defines the transcriptional activity of IRF-1
Kirchhoff, S., Oumard, A., Nourbakhsh, M., Levi, B.-Z., & Häuser, H. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2000.01750.x · Cited by 31
Zoellner, H. F., Filonzi, E. L., Stanton, H., Layton, J., & Hamilton, J. (1992) · Blood · doi:10.1182/blood.v80.11.2805.2805 · Cited by 30
Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation
Nguyen, H., Teskey, L., Lin, R., & Hiscott, J. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202924 · Cited by 24
In vivo formation of IRF-1 homodimers
Kirchhoff, S., Schaper, F., Oumard, A., & Häuser, H. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80019-4 · Cited by 20
Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1
Kim, E., Park, J. S., & Um, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.092 · Cited by 19
RHS 6 coordinately regulates the Th2 cytokine genes by recruiting GATA 3, SATB1, and IRF 4
Hwang, S. S., Jang, S. W., Lee, K., Kim, H. S., & Lee, G. R. (2016) · Allergy · doi:10.1111/all.13078 · Cited by 19
Sun, T., Gao, F., Lin, X., Yu, R., Zhao, Y. B., Luan, J., Li, H., & Song, M. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.06.003 · Cited by 17
Flagged first, then by citations
Research works printed but not linked: 1
- Fleetwood, 2007, Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation, J. Immunol., 178, 5245, 10.4049/jimmunol.178.8.5245 · DOI · Paper page
Cited by
Sorted by citations
Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
Zhang, F., Parayath, N. N., Ene, C., Stephan, S. B., Koehne, A. L., Coon, M. E., Holland, E. C., & Stephan, M. T. (2019) · Nature Communications · doi:10.1038/s41467-019-11911-5 · Cited by 527
Macrophage plasticity: signaling pathways, tissue repair, and regeneration
Yan, L., Wang, J., Cai, X., Liou, Y., Shen, H., Hao, J., Huang, C., Luo, G., & He, W. (2024) · MedComm · doi:10.1002/mco2.658 · Cited by 406
M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds
Wang, Y., Smith, W. W., Hao, D., He, B., & Kong, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.050 · Cited by 330
Alternatively activated macrophages; a double-edged sword in allergic asthma
Abdelaziz, M. H., Abdelwahab, S. F., Wan, J., Cai, W., Wang, H., Cheng, J., Kesavan, D. K., Vasudevan, A., Sadek, A., Su, Z., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02251-w · Cited by 289
Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview
Cheng, H., Wang, Z., Fu, L., & Xu, T. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00421 · Cited by 268
“In addition, interferon regulatory factor (IRF)-1, IRF-5, and IRF-8 are correlated with polarization to the M1 phenotype, while IRF3 and IRF-4 polarize cells to the M2 phenotype (48).”
Background
Metadata
- Authors
- Chistiakov, D. A., Myasoedova, V. A., Revin, V. V., Orekhov, A. N., & Bobryshev, Y. V.
- Affiliations
- Federal Medical Research Centre for Psychiatry and Narcology (RU)
- Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences (RU)
- UNSW Sydney (AU)
- Corresponding author
- Bobryshev, Yuri V.
- Venue
- Immunobiology
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 223
- Issue
- 1
- Pages
- 101-111
- ISSN
- 0171-2985 (ISSN-L)
- OpenAlex
- W2764291671
- Cited by
- 311
- References
- 151
- Citations by year
- 2026: 15 · 2025: 37 · 2024: 29 · 2023: 41 · 2022: 58 · 2021: 48 · 2020: 27 · 2019: 40 · 2018: 16
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Immunobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Russian Science Foundation (#14-15-00112)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Keywords
- interferon regulatory factors, macrophage polarization, M1 macrophages, M2 macrophages, macrophage differentiation, monocyte differentiation, macrophage heterogeneity, macrophage plasticity, IRF1, IRF5, IRF8, IRF3, IRF4, IRF2, atherosclerosis, tissue microenvironment, wound healing
- MeSH terms
- Animals, Cell Differentiation, Gene Expression Regulation, Humans, Macrophages, Cytokines, Th1 Cells, Th2 Cells, Interferon Regulatory Factors, Cell Transdifferentiation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review